The need for population care increases with the age of the population. Pneumonia is the fourth leading cause of death in Japan, yet the risk of pneumonia could be reduced by eliminating opportunistic infection sources such as oral bacteria (e.g. Porphyromonas gingivalis). Previously, we reported removal of P. gingivalis by macrophages during the early stages of cellular immunity, although neither neutrophils nor antibodies participated in the antimicrobial activity. BCG is a live vaccine against tuberculosis, and is thought to maintain cellular immunity as the antigen remains in vivo for longer periods. In this experiment, we attempted to clarify the relationship between aging and the elimination of P. gingivalis by examining the protective capacity of BCG against P. gingivalis infection in mice of various ages. In young mice, the reduction in numbers of P. gingivalis was accompanied by increased IFN-γ and IL-12 levels, and nitric oxide was continuously produced. The augmentation of bactericidal activity, namely the effects of the vaccine, was clear in young mice, but weaker in older mice. Activation of cellular immunity was not observed in older mice, even when boosters were administered. Pneumonia, which is the fourth leading cause of death in Japan (23), results in more deaths among cancer patients than terminal-stage cancer. Among the elderly, many cases of pneumonia occur due to aspiration of indigenous oral bacteria (4), but the causative organism is not considered to be aggressive. The oral bacterium Porphyromonas gingivalis is a gram-negative, anaerobic rod that is the main pathogen associated with adult periodontitis (33). P. gingivalis has recently attracted attention as the pathogenic bacterium found in systemic disorders such as bacterial endocarditis (11,22,25,37) and arteriosclerosis (8, 17) as well as pneumonia (4,27,31). P. gingivalis possesses the protease gingipain, which degrades antibody-complement complexes and confers resistance to phagocytosis (5, 9) and antibiotics (3, 30), enabling it to become an opportunistic infection source. BCG is an attenuated strain of a probiotic bovine bacterium that was first produced by Calmette and Guérin (7) for the prevention of tuberculosis, and is still in widespread use. The antimicrobial properties of macrophages activated by BCG are non-specific, and long-term effective immunization has been reported (18,21,22,36). Although many studies have investigated the immunization efficacy of BCG on tubercle bacilli, few have explored the relationship between vaccination efficiency and aging. Previously, we examined immune responses to oral bacteria and showed that stronger Th1 responses occurred in mice immunized with Fusobacterium nucleatum compared to P. gingivalis (19). In addition, we confirmed that P. gingivalis was removed by macrophage participation during the early stages of cellular immunity (16), although neither neutrophilic leukocytes nor antibodies took part in the antimicrobial activity (26). Accordingly, we questioned